| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965325 | Vaccine | 2015 | 6 Pages |
Abstract
All three PCV vaccines showed high level of protection against IPD caused by serotypes included in their formulation and there was a high level of cross-protection against 19A for PCV10. No substantial difference was seen between PCV10, PCV13, or a mixed PCV10Â +Â PCV13 schedule.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Geneviève Deceuninck, Gaston De Serres, Nicole Boulianne, Brigitte Lefebvre, Philippe De Wals,